Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 30.70M | $ 33.20M | $ 35.40M | $ 8.80M | $ 42.60M |
Total Assets | $ 2.52B | $ 2.45B | $ 2.47B | $ 2.53B | $ 2.53B |
Total Debt | $ 1.62B | $ 1.66B | $ 1.64B | $ 1.63B | $ 1.68B |
Net Debt | $ 1.59B | $ 1.63B | $ 1.60B | $ 1.62B | $ 1.63B |
Total Liabilities | $ 1.87B | $ 2.00B | $ 2.06B | $ 2.05B | $ 2.28B |
Stockholders Equity | $ 648.10M | $ 451.80M | $ 406.40M | $ 480.70M | $ 248.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |